J Cancer 2021; 12(10):2825-2834. doi:10.7150/jca.55553 This issue Cite

Research Paper

Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis

Ji Young Lee1*, Daeun Ryu2*, Sung Won Lim3*, Kyung Ju Ryu1, Myung Eun Choi1, Sang Eun Yoon4, Kihyun Kim4, Chaehwa Park1✉, Seok Jin Kim1,4✉

1. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
2. Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
3. Division of Hematology-Oncology, Department of Medicine, H plus Yangji hospital, Seoul, Korea.
4. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
*These authors contributed equally as co-first authors.

Citation:
Lee JY, Ryu D, Lim SW, Ryu KJ, Choi ME, Yoon SE, Kim K, Park C, Kim SJ. Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis. J Cancer 2021; 12(10):2825-2834. doi:10.7150/jca.55553. https://www.jcancer.org/v12p2825.htm
Other styles

File import instruction

Abstract

Graphic abstract

Background: Exosomes have emerged as important mediators of tumor progression, and a prognostic role for serum exosomal miRNAs has been suggested in multiple myeloma (MM). Given the association of hypoxia with tumor aggressiveness, including cancer stem cell-like phenotypes, we explored exosomal miRNAs from MM cells under hypoxic conditions and analyzed their diverse roles both in promoting oncogenic activity and in predicting prognosis.

Methods: The human MM cell line, RPMI 8226, was cultured under hypoxic conditions and their exosome production and exosomal miRNA profiles were compared with those of normoxic parental cells. The survival outcome of myeloma patients was compared using serum levels of exosomal miRNAs, and the effects of exosomal miRNAs on the target genes of MM cells and adjacent immune cells were analyzed.

Results: Increased expression of stem cell markers and exosome production were observed in hypoxic MM cells. Exosome miRNA analysis identified a higher expression of miR-1305 in exosomes isolated from hypoxic MM cells than in those of normoxic parental cells. The overall survival of patients with high exosomal miR-1305 was poorer than it was in patients with low exosomal miR-1305. In hypoxic MM cells, an increase of exosomal miR-1305 led to a decrease of cellular miR-1305 and increased expression of the miR-1305 target genes, MDM2, IGF1 and FGF2 resulted in the promotion of oncogenic activity of MM. Exosomal miR-1305 was also transferred from MM cells to macrophages, and miR-1305-transferred macrophages showed tumor-promoting, M2-macrophage phenotypes.

Conclusions: Exosome-mediated secretion of miR-1305 in MM cells promoted oncogenic activity of hypoxic MM cells and high serum levels of exosomal miR-1305.

Keywords: exosome, microRNA, miR-1305, multiple myeloma, hypoxia


Citation styles

APA
Lee, J.Y., Ryu, D., Lim, S.W., Ryu, K.J., Choi, M.E., Yoon, S.E., Kim, K., Park, C., Kim, S.J. (2021). Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis. Journal of Cancer, 12(10), 2825-2834. https://doi.org/10.7150/jca.55553.

ACS
Lee, J.Y.; Ryu, D.; Lim, S.W.; Ryu, K.J.; Choi, M.E.; Yoon, S.E.; Kim, K.; Park, C.; Kim, S.J. Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis. J. Cancer 2021, 12 (10), 2825-2834. DOI: 10.7150/jca.55553.

NLM
Lee JY, Ryu D, Lim SW, Ryu KJ, Choi ME, Yoon SE, Kim K, Park C, Kim SJ. Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis. J Cancer 2021; 12(10):2825-2834. doi:10.7150/jca.55553. https://www.jcancer.org/v12p2825.htm

CSE
Lee JY, Ryu D, Lim SW, Ryu KJ, Choi ME, Yoon SE, Kim K, Park C, Kim SJ. 2021. Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis. J Cancer. 12(10):2825-2834.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image